Stereotactic Linear Accelerator Radiotherapy for Pituitary Tumors

Springer Science and Business Media LLC - Tập 3 - Trang 211-216 - 2012
Thankama Ajithkumar1, Michael Brada1
1Neuro-Oncology Unit and Academic Unit of Radiotherapy and Oncology, The Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, Surrey, UK

Tóm tắt

Last decade has seen important advances in radiotherapy technology which combine precise tumor localization with accurate targeted delivery of radiation. This technique of high precision conformal radiotherapy, described as stereotactic radiotherapy or radiosurgery, uses modern linear accelerators available in most radiation oncology departments. The article describes the new technique as applied to the treatment of pituitary adenoma and reviews published clinical results

Tài liệu tham khảo

Perks JR, Jalali R, Cosgrove VP, et al. Optimization of stereotactically-guided conformai treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms. Int J Radiat Oncol Biol Phys 1999; 45(2): 507–13 Solberg TD, Boedeker KL, Fogg R, et al. Dynamic arc radiosurgery field shaping: a comparison with static field conformai and noncoplanar circular arcs. Int J Radiat Oncol Biol Phys 2001; 49(5): 1481–91 Benedict SH, Cardinale RM, Wu Q, et al. Intensity-modulated stereotactic radiosurgery using dynamic micro-multileaf collimation. Int J Radiat Oncol Biol Phys 2001; 50(3): 751–8 Khoo VS, Oldham M, Adams EJ, et al. Comparison of intensity-modulated tomotherapy with stereotactically guided conformai radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys 1999; 45(2): 415–25 Brada M, Rajan B, Traish D, et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol Oxf 1993; 38(6): 571–8 Colao A, Cerbone G, Cappabianca P, et al. Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas. J Endocrinol Invest 1998; 21(5): 284–90 Tsang RW, Brierley JD, Panzarella T, et al. Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiother Oncol 1996; 41(1): 45–53 Tsang RW, Brierley JD, Panzarella T, et al. Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 1994; 30(3): 557–65 Coke C, Andrews DW, Corn BW, et al. Multiple fractionated stereotactic radiotherapy of residual pituitary macroadenomas: initial experience. Stereotact Funct Neurosurg 1997; 69 (1–4 Pt 2): 183–90 Mitsumori M, Shrieve D, Alexander E, et al. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 1998; 42(3): 573–80 Jalali R, Brada M, Perks JR, et al. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience. Clin Endocrinol (Oxf) 2000; 52(6): 695–702 Milker-Zabel S, Debus J, Thilmann C, et al. Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 2001; 50(5): 1279–86 Rocher FP, Sentenac I, Berger C, et al. Stereotactic radiosurgery: the Lyon experience. Acta Neurochir Wien 1995; 63: 109–14 Leber KA, Bergloff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998; 88(1): 43–50 Voges J, Sturm V, Deuss U, et al. LINAC-radiosurgery (LINAC-RS) in pituitary adenomas: preliminary results. Acta Neurochir Suppl (Wien) 1996; 65: 41–3 Yoon SC, Suh TS, Jang HS, et al. Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 1998; 41(4): 849–53